Dr. Linder is active in both the academic and commercial sectors. At the University of Nebraska Medical Center he serves as CEO of UNeMed Corporation, the technology transfer arm of University, he is also Professor of Pathology and Microbiology. In the private sector he is Senior Vice President and Chief Medical Officer of Constitution Medical, a Warburg Pincus portfolio company focused on developing new diagnostic technologies. At the University of Nebraska he previously served as Associate Vice Chancellor for Research, interim dean of Medicine and Director of Surgical Pathology and Cytopathology. Nationally he has led numerous pathology organizations, including the American Society of Clinical Pathologists, the American Society of Cytopathology and the United States/Canadian Academy of Pathology. From 1995 thru 2007 he served as Chief Medical Officer of Cytyc Corporation. Among his awards are the Distinguished Teaching Award of the University of Nebraska, the Award for Excellence in Medical Publications from the American Medical Writers Association, and the Israel Davidsohn award for distinguished service to pathology. He consults with, or serves on the Boards of several private companies. Dr. Linder’s interests have centered on the application of new technology in medical diagnostics, including, molecular and immunodiagnostics, telemedicine and cellular imaging. He earned his undergraduate degrees in Biochemistry and Microbiology from Iowa State University, and his Medical Doctor degree from the University of Nebraska Medical Center, and trained in pathology at Duke University.